Telstar To Install In China An Integrated Automatic Dosing, Freeze-Drying, Sterilization, Unloading And Packing System For The Production Of Antibiotics

• The integrated automatic system is designed for the bulk production of sterile and toxic antibiotics
• This is the largest integrated project to be carried out in China in which a single company, Telstar, provides all of the technology and the entire production process

The Telstar company is to develop a complete, integrated automatic system for dosing, freeze-drying, unloading and end packing of bulk sterile antibiotics for one of the largest Chinese producers of antibiotics and oncological products.

The integrated freeze-drying system will feature an automatic loading and unloading system operating under sterile conditions within a production isolator. Specifically designed for the freeze-drying of antibiotics, the system incorporates a sterile isolator which protects the operator and allows an ISO 5 class manufacturing environment to be maintained. Production operations are carried out by robotic devices inside the isolator so the risk of contamination during human manipulation of the product are eliminated, while the operators are also protected from the toxicity of the product.

The first stage of the process (freeze-drying) is composed of three GMP production freeze-dryers and automatic tray loading and unloading systems installed inside three-chamber sterile isolators, together with equipment to dispense the liquid product into trays. After the freeze drying cycle is complete vacuum unloading systems move the freeze-dried product into IBC containers. The project also includes steam autoclaves and various RAB and isolator systems necessary for other applications associated with the production process..

The second stage of the process involves weighing and packing support for each of the freeze-drying systems. An integrated autoclave is used to steam-sterilize aluminium canisters, which are then dosed from the IBC with a weighed quantity of the freeze-dried product. Packing then completes the process, all of which will operate within an isolator to guarantee operator safety and ISO 5 classification.

Telstar will supply this complete system in triplicate, thereby giving the client greater flexibility in carrying out large-volume production. Telstar's capability to develop and manufacture this system entirely in-house provides the client with a cost-effective solution and assures quality control over the whole process.

The implementation of such a complex integrated project is made possible by close collaboration between Telstar's technological centres: freeze-drying, with headquarters in Shanghai (China); sterilization, based in Granollers (Spain); containment, based in Dewsbury (UK); and loading systems, based in Terrassa (Spain). Telstar will integrate together all of the system elements in its in Chinese headquarters, thereby enabling the client to directly participate in the construction and test of the system.

Through this project, Telstar has become the only international company capable of offering a complete, integrated aseptic dosing, freeze-drying, unloading and packing system for the pharmaceutical industry that utilizes in-house technology and provides a complete production process.

China Pharm. Booth 5529 – Hall W5
Telstar will participate in the China Pharm trade fair, taking place in Shanghai between the 27th and 30th October 2009, where it will be present its range of equipment solutions for life sciences and in particular for pharmaceutical and biotechnology applications. Telstar booth number 5529 – Hall W5.

About Telstar
Telstar develops, provides and services high-tech equipment for the life sciences market, specifically for the biotechnology, nanotechnology, traditional technology and medicine market. Telstar is one of the top 10 Pharmaceutical Process Equipment manufacturers worldwide and one of the few companies in the world that can supply Integrated Process Solutions for the Pharmaceutical Industry.

Founded in 1963, Telstar has diversified its professional activities, experiencing rapid growth and tripling its turnover in the last eight years to reach 111 million euros in the last financial year. Telstar operates in more than one hundred countries and has production plants in Spain, China, the United States, the United Kingdom, Holland and Germany. As a global company, Telstar has a strong presence in the international market, with 80% of its current turnover generated from outside its home in Spain. Based in Terrassa, Barcelona, Telstar has a 750-strong team of professionals.

SOURCE: Telstar